Gravatom has experienced a surge in interest in its PET (Positron Emission Tomography) engineering solutions developed for the nuclear
medicine industry. PET is a vital nuclear imaging technique for the earlier detection of cancers, brain and cardiovascular disorders. Over the past
four years, Gravatom has been applying its extensive knowledge of engineering for GMP production of radiopharmaceuticals towards the
development of systems for the production of PET tracer. For more information please contact Gravatom on 01489 897300, email sales@gravatom.com or visit www.gravatom.com
For more information on this company click here
To add your company click here
Glasgow trial explores AR cues for autonomous road safety
They've ploughed into a few vulnerable road users in the past. Making that less likely will make it spectacularly easy to stop the traffic for...